Cellectis, Precision BioSciences genomics news

Precision said the U.S. Patent and Trademark Office (PTO) issued final decisions and right of appeal notices rejecting patent infringement claims from Cellectis against Precision for Cellectis' U.S. Patents Nos. 6,833,252; 7,214,536; 7,309,605 and 6,610,545. The decisions canceled or rejected 77 of 78 claims from Cellectis. Precision said the remaining claim is "irrelevant" to Precision's business. ...